The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Issaquah, WA

Dr. Porter provides state-of-the-art, minimally invasive treatment options to patients with urologic cancer and stone disease to reduce the pain and recovery from surgical treatment. He stays current on the latest available treatments by teaching at national and international urologic meetings as well as publishing his outcomes. Dr. Porter was the 2023 recipient of the Menon Award in Robotic Urologic Surgery. Dr. Porter is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Vasectomy. Dr. Porter is board certified in American Board Of Urology. Dr. Porter is currently accepting new patients.

I seek to establish an open physician-patient partnership to help guide concerned patients in making informed decisions regarding their care. Dr. Mullen's medical interests include: urologic oncology including robotic surgery and other minimally invasive treatments, bladder cancer and urinary reconstruction, surgical and medical management of kidney stones. Dr. Mullen is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, UPJ Obstruction, Obstructive Uropathy, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Mullen is board certified in American Board Of Urology. Dr. Mullen is currently accepting new patients.

Dr. Zhao believes in providing the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches. Dr. Zhao is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Variegate Porphyria, Hereditary Coproporphyria, Porphyria, and Prostate Cancer. Dr. Zhao is board certified in American Board Of Internal Medicine. Dr. Zhao is currently accepting new patients.

Dr. Lee feels that open, honest communication is fundamental to the patient-doctor relationship, and strives to partner with her patients in a shared decision-making model of care. Dr. Lee has received both regional and national awards for her research in prostate and kidney cancer outcomes and epidemiology. She completed an advanced robotics fellowship in Seattle, WA. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Ureterocele, Reconstructive Urology Surgery, and Nephrectomy. Dr. Lee is board certified in American Board Of Urology. Dr. Lee is currently accepting new patients.

Sarah Psutka is a Urologist practicing medicine in Seattle, Washington. Dr. Psutka is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Psutka is currently accepting new patients.

Paul Kozlowski, MD, is a board-certified urologist specializing in minimally invasive laparoscopic and robotic surgery for a variety of urologic conditions, including kidney and other urologic cancers, prostate disease and kidney stones (including complex stones). He is experienced with both robotic and radical prostatectomy; renal reconstructive surgery; and ureteropelvic junction obstruction (UPJ). Dr. Kozlowski also offers aquablation treatment for benign prostate hyperplasia (HPB).Dr. Kozlowski strives to put himself in the patient's chair so he can better understand and relieve their concerns and anxieties. He savors his time with his patients and works hard to earn their trust.Dr. Kozlowski is a member of the American Urological Association, Endourological Society and Western Section of the American Urologic Association. He is a Pfizer Scholar in Urology and an associate clinical professor at the University of Washington. Dr. Kozlowski is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Ureterocele, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery. Dr. Kozlowski is board certified in American Board Of Urology. Dr. Kozlowski is currently accepting new patients.

John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Prostatectomy, and Splenectomy. Dr. Flores is board certified in American Board Of Internal Medicine, Subspecialty In Medical Oncology. Dr. Flores is currently accepting new patients.

Dr. Wahl is a native of the Pacific Northwest and a perennial winner of the Seattle Met Top Doctor award. Dr. Wahl graduated from the University of Washington with a BS in Technical Communication and attended Duke School of Medicine in Durham, North Carolina. There she received a Stead Scholarship and a Howard Hughes Medical Institute Research Fellowship, studying cell signal transduction in yeast. She completed Internal Medicine Residency and Chief Residency at Stanford University Hospital and Medical Center in Palo Alto, California and returned to Seattle to complete her Hematology Fellowship at University of Washington/Fred Hutchinson Cancer Research Center. Dr. Wahl is Board Certified in Medical Oncology and has been in practice since 2003. She is happy to care for patients with any cancer diagnosis and has a special interest in breast cancer, gynecologic malignancies and clinical research. She particularly enjoys working with patients collaboratively in order to optimize the quality of the care they receive. Dr. Wahl is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Ampullary Cancer, Angiosarcoma, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Wahl is board certified in American Board Of Internal Medicine. Dr. Wahl is currently accepting new patients.

I strive to provide personalized, cutting-edge therapy in a multidisciplinary setting. I offer patients and families understandable knowledge in order for them to navigate the illness and treatment process, and to build true partnerships with compassion, empathy and respect. Dr. Xie is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Xie is board certified in American Board Of Internal Medicine. Dr. Xie is currently accepting new patients.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, Nerve Decompression, and Laminectomy. Dr. Subramaniam is board certified in American Board Of Internal Medicine. Dr. Subramaniam is currently accepting new patients.

David Dong is an Oncologist practicing medicine in Issaquah, Washington. Dr. Dong is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Angiosarcoma, Pleuropulmonary Blastoma, and Lung Cancer.

Jason Lukas is an Oncologist practicing medicine in Issaquah, Washington. Dr. Lukas is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Multiple Myeloma, and Paget Disease of the Breast.

Daniel Smoots is a Radiologist practicing medicine in Bellevue, Washington. Dr. Smoots is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, WT1-Related Wilms Tumor Syndromes, Chronic Cough, and Pleurisy.

Mark Zobel is a Radiologist practicing medicine in Bellevue, Washington. Dr. Zobel is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, WT1-Related Wilms Tumor Syndromes, Chronic Cough, and Gallbladder Disease.

Christian Kuhr, MD, is a board-certified urologist with special medical interest in kidney and pancreas transplantation and kidney cancer surgery. Dr. Kuhr's lab focuses on the mechanisms of immune tolerance as they relate to organ transplantation and cancer treatment.Dr. Kuhr feels privileged to work with patients and to witness the transformative effects of transplantation, both for the patients and their families. The process of transplant surgery requires a lot of trust between patient and physician, and Dr. Kuhr works hard to built this trust.Dr. Kuhr is a Fellow of the American College of Surgeons. He is part of Benaroya Research Institute, a clinical associate professor of surgery and urology at the University of Washington, and affiliate in research at Fred Hutchinson Cancer Research Center. He has been named a Top Doctor bySeattle MetropolitanandSeattlemagazines.When not caring for patients or in the laboratory, Dr. Kuhr enjoys spending time with his wife, two children and dog, hiking, climbing, skiing, cycling and running. He also enjoys the outdoors, travel and music. Dr. Kuhr is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Nephrectomy, and Reconstructive Urology Surgery. Dr. Kuhr is board certified in Diplomate, American Board Of Urology. Dr. Kuhr is currently accepting new patients.

Nick Cowan, MD, is a board certified urologist and transplant surgeon specializing in kidney transplant, kidney cancer, kidney stones, and laparoscopic and robotic urologic surgery. He also offers aquablation treatment for benign prostate hyperplasia (BPH).Dr. Cowan is the Urology Residency Program director at Virginia Mason and a clinical assistant professor of urology at the University of Washington. He is a member of the American Urologic Association, and the Urologic Society for Transplantation and Renal Surgery. He serves as a manuscript reviewer withUrology Practice, Urology, Journal of UrologyandClinical Transplantation.Away from work, Dr. Cowan enjoys surfing, skiing and backpacking. Dr. Cowan is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Ureterocele, UPJ Obstruction, Reconstructive Urology Surgery, and Nephrectomy. Dr. Cowan is board certified in American Board Of Urology. Dr. Cowan is currently accepting new patients.

Ishwar Bhat is a Radiologist practicing medicine in Seattle, Washington. Dr. Bhat is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Gallbladder Disease, and Progressive Familial Intrahepatic Cholestasis Type 2.

Mehran Fotoohi, MD, specializes in interventional radiology, including peripheral vascular disease, pancreatitis, minimally invasive oncologic treatments, chemoembolization and radiofrequency ablation, and ultrasound exams. Dr. Fotoohi is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Ascites, Lung Nodules, Liver Embolization, and Gastrostomy. Dr. Fotoohi is board certified in American Board Of Radiology. Dr. Fotoohi is currently accepting new patients.

Brian Winters is a Urologist practicing medicine in Bellevue, Washington. Dr. Winters is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Reconstructive Urology Surgery.

Joshua Wilfong is a Hematologist and an Oncologist practicing medicine in Bellevue, Washington. He has been practicing medicine for over 17 years. Dr. Wilfong is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Non-Hodgkin Lymphoma, and Gastric Lymphoma.